1-3 of 3
Takuya Suzuki
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dose Escalation Data from the Phase 1 Study of the Liposomal Formulation of Eribulin (E7389-LF) in Japanese Patients with Advanced Solid Tumors

Jun Sato, Toshio Shimizu, Takafumi Koyama, Satoru Iwasa, Akihiko Shimomura, Shunsuke Kondo, Shigehisa Kitano, Kan Yonemori, Yutaka Fujiwara, Kenji Tamura, Takuya Suzuki, Takao Takase, Reiko Nagai, Kohei Yamaguchi, Taro Semba, Zi-Ming Zhao, Min Ren, Noboru Yamamoto
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (9): 1783–1791.
DOI: https://doi.org/10.1158/1078-0432.CCR-21-3518
Published: 02 May 2022
View article
PDF
Includes: Supplementary data
Journal Articles

A Randomized, Phase III Study of Lenvatinib in Chinese Patients with Radioiodine-Refractory Differentiated Thyroid Cancer

Xiangqian Zheng, Zhengang Xu, Qinghai Ji, Minghua Ge, Feng Shi, Jianwu Qin, Feng Wang, Guang Chen, Yuan Zhang, Rui Huang, Jian Tan, Tao Huang, Sijin Li, Zhongwei Lv, Yansong Lin, Zhuming Guo, Tomoki Kubota, Takuya Suzuki, Hiroki Ikezawa, Ming Gao
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (20): 5502–5509.
DOI: https://doi.org/10.1158/1078-0432.CCR-21-0761
Published: 15 October 2021
View article
PDF
Includes: Supplementary data
Journal Articles

Safety and Pharmacokinetics of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma

Masafumi Ikeda, Takuji Okusaka, Shuichi Mitsunaga, Hideki Ueno, Toshiyuki Tamai, Takuya Suzuki, Seiichi Hayato, Tadashi Kadowaki, Kiwamu Okita, Hiromitsu Kumada
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (6): 1385–1394.
DOI: https://doi.org/10.1158/1078-0432.CCR-15-1354
Published: 14 March 2016
View article
PDF
Includes: Supplementary data